1. Home
  2. TIL vs NA Comparison

TIL vs NA Comparison

Compare TIL & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$6.11

Market Cap

52.2M

Sector

Health Care

ML Signal

HOLD

NA

Nano Labs Ltd

SELL

Current Price

$1.98

Market Cap

51.9M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
TIL
NA
Founded
2018
2019
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
52.2M
51.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
TIL
NA
Price
$6.11
$1.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.6K
★ 28.8K
Earning Date
11-12-2026
08-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 6.06
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.67
$1.58
52 Week High
$20.32
$5.24

Technical Indicators

Market Signals
Indicator
TIL
NA
Relative Strength Index (RSI) 30.65 47.96
Support Level N/A $1.64
Resistance Level $8.10 $2.13
Average True Range (ATR) 0.31 0.15
MACD -0.09 -0.04
Stochastic Oscillator 15.23 53.33

Price Performance

Historical Comparison
TIL
NA

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

Share on Social Networks: